Albert G. White III Sells 114,992 Shares of The Cooper Companies, Inc. (NASDAQ:COO) Stock

The Cooper Companies, Inc. (NASDAQ:COO) CEO Albert G. White III sold 114,992 shares of the business’s stock in a transaction on Thursday, September 19th. The stock was sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the sale, the chief executive officer now owns 165,273 shares in the company, valued at $18,267,624.69. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

Cooper Companies Trading Down 0.5 %

Cooper Companies stock opened at $110.49 on Friday. The stock has a 50-day moving average price of $97.93 and a 200 day moving average price of $95.50. The Cooper Companies, Inc. has a 52 week low of $75.93 and a 52 week high of $112.38. The stock has a market cap of $22.00 billion, a PE ratio of 64.99, a P/E/G ratio of 2.60 and a beta of 0.98. The company has a current ratio of 1.99, a quick ratio of 1.18 and a debt-to-equity ratio of 0.33.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.05. The business had revenue of $1 billion during the quarter, compared to the consensus estimate of $997.30 million. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The company’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.84 earnings per share. Equities research analysts predict that The Cooper Companies, Inc. will post 3.66 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the business. Benjamin F. Edwards & Company Inc. grew its stake in shares of Cooper Companies by 248.6% during the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 244 shares of the medical device company’s stock valued at $25,000 after buying an additional 174 shares during the period. Brown Brothers Harriman & Co. raised its stake in shares of Cooper Companies by 412.2% during the fourth quarter. Brown Brothers Harriman & Co. now owns 251 shares of the medical device company’s stock valued at $95,000 after purchasing an additional 202 shares during the period. Covestor Ltd lifted its position in shares of Cooper Companies by 305.9% during the first quarter. Covestor Ltd now owns 276 shares of the medical device company’s stock worth $28,000 after purchasing an additional 208 shares in the last quarter. Innealta Capital LLC purchased a new position in shares of Cooper Companies in the second quarter valued at $25,000. Finally, Crewe Advisors LLC increased its stake in Cooper Companies by 286.4% during the 2nd quarter. Crewe Advisors LLC now owns 340 shares of the medical device company’s stock worth $30,000 after buying an additional 252 shares during the period. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on COO shares. Jefferies Financial Group upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating and upped their target price for the stock from $107.00 to $115.00 in a research report on Tuesday, July 16th. Wells Fargo & Company upped their price target on Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a report on Thursday, August 29th. Stifel Nicolaus reaffirmed a “buy” rating and set a $115.00 price objective (up from $110.00) on shares of Cooper Companies in a report on Thursday, August 29th. Morgan Stanley boosted their target price on Cooper Companies from $95.00 to $104.00 and gave the stock an “equal weight” rating in a research report on Tuesday, September 10th. Finally, Piper Sandler raised their price target on Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a research report on Thursday, August 29th. Four equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $115.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.